by Serena Gordon, Healthday Reporter
Blood sugar goals higher for some; Asian-Americans need screening at lower weights; statins for those over 40
(HealthDay)— When caring for people with diabetes, primary care doctors need to tailor blood sugar targets and treatments to the individual patient, new recommendations suggest.
That's just one of the guidelines highlighted in an article that experts from the Joslin Diabetes Center in Boston published in the March 23 issue of the Annals of Internal Medicine.
The article summarizes important changes in the American Diabetes Association's (ADA) 2015 Standards of Care guidelines, which include screening Asian-Americans for diabetes at lower weights and giving statins to anyone with diabetes who is over 40.
"This extends the opportunity for primary care physicians who see the bulk of patients with diabetes to be exposed to the guidelines. We choose three areas from the guidelines we thought needed highlighting," said senior author Dr. Martin Abrahamson, senior vice president and medical director of the Joslin Diabetes Center.
One of the important areas in the ADA's guidelines is the need to consider patients as individuals and tailor treatments accordingly. Age, other medical conditions, life expectancy, as well as the patient's motivation and preferences all need to be considered when choosing therapies and setting blood sugar goals, according to the authors of the article.
Metformin is generally the first drug of choice in type 2 diabetes. If metformin fails to control blood sugar levels, it's not always clear what the best drug choice would be. However, there are currently ongoing studies trying to answer that question, noted Abrahamson and his colleague, Dr. Giulio Romero.
"An A1C of under 7 is still the general recommendation, unless you're someone who's older or has more complications. The good news for many people is that there are many more drugs that can be used that do not cause hypoglycemia [dangerously low blood sugar] that make it easier to reach the A1C target," Abrahamson said.
A1C is a blood test that estimates average blood sugar levels over two to three months. Previous research has shown that keeping A1C levels below 7 is associated with a lower risk of diabetes complications.
A second issue the authors noted is that Asian-Americans start developing diabetes at lower weights. "Overweight and obesity are not one-size-fits-all. If you're Asian-American, a body mass index (BMI) of 23 is overweight," Abrahamson said.
Body mass index is a rough estimate of body fat that is based on height and weight. In general, a BMI of 25 is considered overweight, according to the U.S. Centers for Disease Control and Prevention.
The authors said the reason Asian-Americans have a greater risk of diabetes at a lower weight is because their fat tends to deposit around their internal organs. This is known as visceral fat, and it increases the risk of insulin resistance, a precursor to type 2 diabetes. For this reason, the ADA recommended that type 2 diabetes screening in Asian-Americans should start if their BMI is 23 or higher, rather than at 25.
The final recommendation highlighted dealt with heart disease risk. People with both type 1 and type 2 diabetes have a significantly increased risk of developing heart disease. Because of this, the ADA recommended that doctors should begin cholesterol-lowering medications called statins in anyone over 40 with diabetes, even if they don't have high cholesterol.
"If you have diabetes, you're already at risk for heart disease. The ADA guidelines say if you have diabetes and you're between 40 and 75, you should be on a statin," Abrahamson noted.
Dr. Sam Altstein, a family medicine doctor and medical director of the Mount Sinai Beth Israel Medical Group in New York City, said none of the recommendations would be difficult to incorporate into practice.
"Doctors are very good at tailoring treatment to specific individuals. Patients don't always fit into algorithms—they may be elderly or very sick—so, we have to make adjustments," Altstein said.
Altstein said the biggest challenge in treating people with type 2 diabetes is that "when someone comes in with type 2, they often have 10 to 20 years of unhealthy living under their belt. It's easy to figure out which medications they should be one, but getting people to change how they live is a lot like asking someone to change their religion. People have a hard time changing. It's very hard to undo a lifetime of habits," he said, adding that a referral to a dietician is often helpful.
He also recommended that patients "connect with your doctor and ask what your doctor feels a realistic goal is for you." For example, someone who's very overweight may not be able to lose 100 pounds, but they might feel 20 pounds is possible. "And, from a physiologic perspective, modest decreases in weight can lead to substantial changes in diabetes," Altstein said.
Explore further: Asians need type 2 diabetes screening at lower body weight: experts
More information: Learn more about the management of type 2 diabetes from the American Diabetes Association.
Copyright © 2015 HealthDay. All rights reserved.
Medical Xpress on facebook
Related Stories
Asians need type 2 diabetes screening at lower body weight: experts
(HealthDay)—Obesity is a big contributor to type 2 diabetes, but Asian-Americans may need to pile on fewer excess pounds to develop the disease than other groups do, according to new guidelines from the ...
Popular diabetes drug may be safe for patients with kidney disease
The most popular treatment for type 2 diabetes, metformin, may be safer for patients with mild to moderate kidney disease than guidelines suggest, according to a new, systematic review of the literature published by Yale ...
Diabetes groups issue new guidelines on blood sugar
(HealthDay) -- Type 2 diabetes is a complex metabolic disorder, and treating the disease often requires a personalized, multi-pronged approach, say new expert guidelines on treating high blood sugar levels, ...
US doctors, CDC join forces in new diabetes prevention effort
(HealthDay)—Reducing the number of Americans with type 2 diabetes is a new mission shared by the American Medical Association (AMA) and the leading U.S. health agency, officials said Thursday.
Metformin beats other type 2 diabetes drugs for first treatment: study
(HealthDay)—People newly diagnosed with type 2 diabetes who are initially given the drug metformin are less likely to eventually need other drugs to control their blood sugar, a new study suggests.
Recommended for you
Promising vaccine strategy for type 1 diabetes extended to humans
A molecule that prevents Type 1 diabetes in mice has provoked an immune response in human cells, according to researchers at National Jewish Health and the University of Colorado. The findings, published online ...
Expanding Medicaid under ACA helped to identify 23 percent more people with undiagnosed diabetes
States that have expanded their Medicaid programs under the Affordable Care Act (ACA) are capturing an increased number of people with previously undiagnosed diabetes, allowing them to begin treatment earlier, potentially ...
Higher fitness level tied to lower diabetes risk
(HealthDay)—Higher cardio-respiratory fitness is associated with a lower risk of incident diabetes, regardless of demographic characteristics, according to a study published online March 12 in Diabetes Ca ...
Strength training may cut type 2 diabetes risk in Asian workers
(HealthDay)—Strength training may help cut the risk of incident type 2 diabetes in a working-age Asian population, according to a study published online March 2 in the Journal of Diabetes Investigation.
Stem cells show promise for reversing type 2 diabetes
Scientists at the University of British Columbia and BetaLogics, part of Janssen Research & Development, LLC have shown for the first time that Type 2 diabetes can be effectively treated with a combination ...
Following gestational diabetes, obese women who put on 5 kg much more likely to develop type 2 diabetes
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that in women who have developed gestational diabetes mellitus (GDM) during pregnancy, being obese before the pr ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
by Serena Gordon, Healthday Reporter
Blood sugar goals higher for some; Asian-Americans need screening at lower weights; statins for those over 40
(HealthDay)— When caring for people with diabetes, primary care doctors need to tailor blood sugar targets and treatments to the individual patient, new recommendations suggest.
That's just one of the guidelines highlighted in an article that experts from the Joslin Diabetes Center in Boston published in the March 23 issue of the Annals of Internal Medicine.
The article summarizes important changes in the American Diabetes Association's (ADA) 2015 Standards of Care guidelines, which include screening Asian-Americans for diabetes at lower weights and giving statins to anyone with diabetes who is over 40.
"This extends the opportunity for primary care physicians who see the bulk of patients with diabetes to be exposed to the guidelines. We choose three areas from the guidelines we thought needed highlighting," said senior author Dr. Martin Abrahamson, senior vice president and medical director of the Joslin Diabetes Center.
One of the important areas in the ADA's guidelines is the need to consider patients as individuals and tailor treatments accordingly. Age, other medical conditions, life expectancy, as well as the patient's motivation and preferences all need to be considered when choosing therapies and setting blood sugar goals, according to the authors of the article.
Metformin is generally the first drug of choice in type 2 diabetes. If metformin fails to control blood sugar levels, it's not always clear what the best drug choice would be. However, there are currently ongoing studies trying to answer that question, noted Abrahamson and his colleague, Dr. Giulio Romero.
"An A1C of under 7 is still the general recommendation, unless you're someone who's older or has more complications. The good news for many people is that there are many more drugs that can be used that do not cause hypoglycemia [dangerously low blood sugar] that make it easier to reach the A1C target," Abrahamson said.
A1C is a blood test that estimates average blood sugar levels over two to three months. Previous research has shown that keeping A1C levels below 7 is associated with a lower risk of diabetes complications.
A second issue the authors noted is that Asian-Americans start developing diabetes at lower weights. "Overweight and obesity are not one-size-fits-all. If you're Asian-American, a body mass index (BMI) of 23 is overweight," Abrahamson said.
Body mass index is a rough estimate of body fat that is based on height and weight. In general, a BMI of 25 is considered overweight, according to the U.S. Centers for Disease Control and Prevention.
The authors said the reason Asian-Americans have a greater risk of diabetes at a lower weight is because their fat tends to deposit around their internal organs. This is known as visceral fat, and it increases the risk of insulin resistance, a precursor to type 2 diabetes. For this reason, the ADA recommended that type 2 diabetes screening in Asian-Americans should start if their BMI is 23 or higher, rather than at 25.
The final recommendation highlighted dealt with heart disease risk. People with both type 1 and type 2 diabetes have a significantly increased risk of developing heart disease. Because of this, the ADA recommended that doctors should begin cholesterol-lowering medications called statins in anyone over 40 with diabetes, even if they don't have high cholesterol.
"If you have diabetes, you're already at risk for heart disease. The ADA guidelines say if you have diabetes and you're between 40 and 75, you should be on a statin," Abrahamson noted.
Dr. Sam Altstein, a family medicine doctor and medical director of the Mount Sinai Beth Israel Medical Group in New York City, said none of the recommendations would be difficult to incorporate into practice.
"Doctors are very good at tailoring treatment to specific individuals. Patients don't always fit into algorithms—they may be elderly or very sick—so, we have to make adjustments," Altstein said.
Altstein said the biggest challenge in treating people with type 2 diabetes is that "when someone comes in with type 2, they often have 10 to 20 years of unhealthy living under their belt. It's easy to figure out which medications they should be one, but getting people to change how they live is a lot like asking someone to change their religion. People have a hard time changing. It's very hard to undo a lifetime of habits," he said, adding that a referral to a dietician is often helpful.
He also recommended that patients "connect with your doctor and ask what your doctor feels a realistic goal is for you." For example, someone who's very overweight may not be able to lose 100 pounds, but they might feel 20 pounds is possible. "And, from a physiologic perspective, modest decreases in weight can lead to substantial changes in diabetes," Altstein said.
Explore further: Asians need type 2 diabetes screening at lower body weight: experts
More information: Learn more about the management of type 2 diabetes from the American Diabetes Association.
Copyright © 2015 HealthDay. All rights reserved.
Medical Xpress on facebook
Related Stories
Asians need type 2 diabetes screening at lower body weight: experts
(HealthDay)—Obesity is a big contributor to type 2 diabetes, but Asian-Americans may need to pile on fewer excess pounds to develop the disease than other groups do, according to new guidelines from the ...
Popular diabetes drug may be safe for patients with kidney disease
The most popular treatment for type 2 diabetes, metformin, may be safer for patients with mild to moderate kidney disease than guidelines suggest, according to a new, systematic review of the literature published by Yale ...
Diabetes groups issue new guidelines on blood sugar
(HealthDay) -- Type 2 diabetes is a complex metabolic disorder, and treating the disease often requires a personalized, multi-pronged approach, say new expert guidelines on treating high blood sugar levels, ...
US doctors, CDC join forces in new diabetes prevention effort
(HealthDay)—Reducing the number of Americans with type 2 diabetes is a new mission shared by the American Medical Association (AMA) and the leading U.S. health agency, officials said Thursday.
Metformin beats other type 2 diabetes drugs for first treatment: study
(HealthDay)—People newly diagnosed with type 2 diabetes who are initially given the drug metformin are less likely to eventually need other drugs to control their blood sugar, a new study suggests.
Recommended for you
Promising vaccine strategy for type 1 diabetes extended to humans
A molecule that prevents Type 1 diabetes in mice has provoked an immune response in human cells, according to researchers at National Jewish Health and the University of Colorado. The findings, published online ...
Expanding Medicaid under ACA helped to identify 23 percent more people with undiagnosed diabetes
States that have expanded their Medicaid programs under the Affordable Care Act (ACA) are capturing an increased number of people with previously undiagnosed diabetes, allowing them to begin treatment earlier, potentially ...
Higher fitness level tied to lower diabetes risk
(HealthDay)—Higher cardio-respiratory fitness is associated with a lower risk of incident diabetes, regardless of demographic characteristics, according to a study published online March 12 in Diabetes Ca ...
Strength training may cut type 2 diabetes risk in Asian workers
(HealthDay)—Strength training may help cut the risk of incident type 2 diabetes in a working-age Asian population, according to a study published online March 2 in the Journal of Diabetes Investigation.
Stem cells show promise for reversing type 2 diabetes
Scientists at the University of British Columbia and BetaLogics, part of Janssen Research & Development, LLC have shown for the first time that Type 2 diabetes can be effectively treated with a combination ...
Following gestational diabetes, obese women who put on 5 kg much more likely to develop type 2 diabetes
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that in women who have developed gestational diabetes mellitus (GDM) during pregnancy, being obese before the pr ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
0 comments:
Post a Comment